Development of pulmonary and cardiac sarcoidosis during etanercept therapy

MeSH terms

• Aged
• Antirheumatic Agents / adverse effects*
• Arthritis, Rheumatoid / diagnosis
• Arthritis, Rheumatoid / drug therapy*
• Arthritis, Rheumatoid / immunology
• Cardiomyopathies / chemically induced*
• Cardiomyopathies / diagnosis
• Cardiomyopathies / drug therapy
• Etanercept
• Female
• Glucocorticoids / therapeutic use
• Humans
• Immunoglobulin G / adverse effects*
• Prednisolone / therapeutic use
• Receptors, Tumor Necrosis Factor
• Risk Factors
• Sarcoidosis / chemically induced*
• Sarcoidosis / diagnosis
• Sarcoidosis / drug therapy
• Sarcoidosis, Pulmonary / chemically induced*
• Sarcoidosis, Pulmonary / diagnosis
• Sarcoidosis, Pulmonary / drug therapy
• Time Factors
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors